Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Leukemia 2Tuberous Sclerosis 1Tourette Syndrome 1Tic Disorders 1Preleukemia 1Neurodevelopmental Disorders 1Myelodysplastic Syndromes 1Leukemia, Myeloid, Acute 1Hematologic Diseases 1Glioblastoma 1Fragile X Syndrome 1DiGeorge Syndrome 1Depression 1Cytopenia 1Bone Marrow Diseases 1Autistic Disorder 1Autism Spectrum Disorder 1Attention Deficit Disorder with Hyperactivity 1Anxiety Disorders 1Anemia 122q11 Deletion Syndrome 1

Interventions

Everolimus 18Sirolimus 15Cannabidiol 5radiprodil 3ganaxolone 3Vigabatrin 3Activator Appliances 3Melatonin 2exemestane 1dactolisib 1carbon-11 acetate 1Surveys and Questionnaires 1Simvastatin 1Sertraline 1Selective Serotonin Reuptake Inhibitors 1Propranolol 1Itraconazole 1Injections 1Fluid Therapy 1Doxycycline 1Curcumin 1Carbamazepine 1Calcitriol 1Aspirin 1Anticonvulsants 1Actigraphy 1Acceptance and Commitment Therapy 12-chloro-4-(1-(4-fluorophenyl)-2,5-dimethyl-1H-imidazol-4-ylethynyl)pyridine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Tuberous Sclerosis × Sertraline × Clear all
NCT06081348 2025-07-16

CALM

Holland Bloorview Kids Rehabilitation Hospital

Phase 2 Recruiting
130 enrolled

Autism Spectrum Disorder, Anxiety Disorders, Attention Deficit Disorder with Hyperactivity, Autistic Disorder, DiGeorge Syndrome, Fragile X Syndrome, Tourette Syndrome, Tic Disorders, Tuberous Sclerosis, 22q11 Deletion Syndrome, Neurodevelopmental Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡